# A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers

> **NCT01115322** · PHASE1 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 38 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Tazarotene Foam without irradiation
- **DRUG:** Tazarotene Foam with UVA and UVB irradiation
- **DRUG:** Tazarotene Foam with UVA, UVB, and visible light
- **DRUG:** Vehicle Foam without irradiation
- **DRUG:** Vehicle Foam with UVA and UVB irradiation
- **DRUG:** Vehicle Foam with UVA and UVB and visible light irradiation
- **DRUG:** No Treatment without irradiation
- **DRUG:** No Treatment with UVA and UVB irradiation
- **DRUG:** No Treatment with UVA and UVB and visible light irradiation

## Key facts

- **NCT ID:** NCT01115322
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04-01
- **Primary completion:** 2010-04-10
- **Final completion:** 2010-04-10
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01115322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01115322, "A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01115322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*